close
close

Champions Oncology reports quarterly revenue of $14.1 million, adjusted EBITDA of $2.0 million

Champions Oncology reports quarterly revenue of .1 million, adjusted EBITDA of .0 million

HACKSENSACK, NJ / ACCESSWIRE / September 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global provider of preclinical and clinical research services delivering end-to-end oncology solutions, today announced financial results for its first …

HACKSENSACK, NJ / ACCESSWIRE / September 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global provider of preclinical and clinical research services delivering end-to-end oncology solutions, today announced its financial results for the first quarter of fiscal year 2025, ended July 31, 2024.

Highlights of the first quarter:

Show more

We are a preeminent news service and are quickly becoming an industry disruptor. We provide regional, national and global news to thousands of customers around the world. We are also leaders in social engagement, targeting and analytics.

Show more

Subscribe to RSS feed

Related Post